Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Omega-3 fatty acids, particularly EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), have scientific support for their role in supporting the female reproductive system. Multiple studies suggest that these polyunsaturated fatty acids can positively influence menstrual health, fertility, and pregnancy outcomes. For example, omega-3 supplementation has been associated with reduced menstrual pain (dysmenorrhea) and decreased severity of premenstrual syndrome (PMS) symptoms, likely due to their anti-inflammatory properties and effects on prostaglandin synthesis. In the context of fertility, some research indicates that higher intake of omega-3s may improve oocyte quality, embryo implantation, and overall fertility, especially in women undergoing assisted reproductive technologies. Additionally, during pregnancy, omega-3s are critical for fetal neurodevelopment, and adequate intake is linked to reduced risk of preterm birth and may support maternal mood. While there is a growing body of evidence supporting these benefits, most findings are moderate in strength, and further large-scale, high-quality clinical trials are needed to fully clarify the magnitude of these effects and optimal dosing. Overall, omega-3 fatty acids are considered beneficial for various aspects of female reproductive health, with a reasonable level of scientific validation, but with some limitations in the current evidence base.

More about omega-3 fatty acids
More about Female Reproductive System

Other ingredients that support Female Reproductive System

Other body systems supported by omega-3 fatty acids

Products containing omega-3 fatty acids

Nature's Sunshine Flax Seed Oil (With Lignans)